IP Library › Assignment 031217/0148
Patent Assignment
Reel/Frame 031217/0148

Change of Name

Recorded: 2013-09-13 Pages: 3
Assignor
ABBOTT BIOTECHNOLOGY LTD.
Executed: 2012-06-25
Assignee
ABBVIE BIOTECHNOLOGY LTD.
2 CHURCH STREET, CLARENDON HOUSE, HAMILTON, HM 11, BERMUDA
Covered Properties (3)
Formulation of human antibodies for treating TNF-alpha associated disorders
Application: 10/222,140 →
Publication: US 2004/0033228
Formulation of Human Antibodies for Treating Tnf-Alpha Associated Disorders
Patent: 8,216,583 →
Application: 10/525,292 →
Publication: US 2006/0153846
Formulation of Human Antibodies for Treating Tnf-Alpha Associated Disorders
Patent: 8,932,591 →
Application: 13/471,820 →
Publication: US 2012/0282270
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2003
From: KRAUSE, HANS-JUERGEN; BAUST, LISA; DICKES, MICHAEL
To: ABBOTT BIOTECHNOLOGY LTD.
Reel/Frame 014389/0458 →
Assignment of Assignor's Interest Oct 27, 2005
From: KRAUSE, HANS-JUERGEN; BAUST, LISA; DICKES, MICHAEL
To: ABBOTT BIOTECHNOLOGY LTD.
Reel/Frame 016950/0087 →
Assignment of Assignor's Interest Jul 26, 2012
From: KRAUSE, HANS-JUERGEN; BAUST, LISA; DICKES, MICHAEL
To: ABBOTT BIOTECHNOLOGY LTD.
Reel/Frame 028648/0720 →